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Objective: Despite multiple studies over more than 3 decades, there still is no consensus about the influence of anesthesia
type on postoperative outcomes following carotid endarterectomy (CEA). The objective of this study was to investigate
whether anesthesia type, either general anesthesia (GA) or regional anesthesia (RA), independently contributes to the risk
of postoperative cardiovascular complications or death using the American College of Surgeons’ National Surgical
Quality Improvement Program (ACS NSQIP) database.
Methods: Retrospective analysis of elective cases of CEA from 2005 through 2009 was performed. A propensity score
model using 45 covariates, including demographic factors, comorbidities, stroke history, measures of general health, and
laboratory values, was used to adjust for bias and to determine the independent influence of anesthesia type on
postoperative stroke, myocardial infarction (MI), and death.
Results:Of 26,070 cases listed in the ACS NSQIP database, GA and RA were used in 22,054 (84.6%) and 4016 (15.4%)
cases, respectively. Postoperative stroke, MI, and death occurred in 360 (1.63%), 133 (0.6%), and 154 (0.70%) patients
of the GA group, respectively, and in 58 (1.44%), 11 (0.27%), and 27 (0.67%) patients of the RA group, respectively.
Stratification by propensity score quintile and adjustment for covariates demonstrated GA to be a significant risk factor
for postoperative MI with an adjusted odds ratio (OR) and confidence interval (CI) of 2.18 (95% CI, 1.17-4.04), P .01
in the entire study population. The OR forMI was 5.41 (95% CI, 1.32-22.16; P .019) in the subgroup of patients with
preoperative neurologic symptoms, and 1.44 (95% CI, 0.71-2.90; P  .31) in the subgroup of patients without
preoperative neurologic symptoms.
Conclusions: This analysis of a large, prospectively collected and validated multicenter database indicates that GA for CEA
is an independent risk factor for postoperative MI, particularly in patients with preoperative neurologic symptoms.
(J Vasc Surg 2012;56:81-8.)
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eIn the 1990s, the North American Symptomatic Ca-
rotid Endarterectomy Trial (NASCET)1 and the European
Carotid Surgery Trial (ECST)2 established carotid endar-
terectomy (CEA) as the gold standard for the treatment of
symptomatic moderate to high-grade carotid artery steno-
sis. In selected patients, superior outcomes of surgical
intervention as compared to medical treatment for high-
grade asymptomatic carotid artery stenosis followed,3,4 but
the clear benefit of surgery demonstrated at that time has
since then been challenged by refinement of nonoperative
care for carotid artery stenosis. Better medication, most
notably statins,5 and stronger antiplatelet agents, as well as
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ave been proposed as alternatives to open surgery.
Numerous studies have confirmed the safety of CEA
ut have also identified risk factors for perioperative com-
lications, particularly stroke, myocardial infarction (MI),
nd nerve injury.6-8 CEA is most commonly performed
nder general anesthesia (GA); alternatively, regional anes-
hesia (RA) using a cervical plexus block may be employed.
he influence of anesthesia type on postoperative outcomes
as been a controversial topic, and studies have been con-
radictory. While some studies suggested better outcomes
ith RA,9-11 other studies found no significant differences
etween GA and RA.12,13 The largest multicenter, ran-
omized controlled trial to date, GALA (General Anesthe-
ia versus Local Anesthesia for carotid surgery), also did not
emonstrate a statistically significant difference between
A and RA with regard to postoperative stroke, MI, or
eath within 30 days after surgery.13
The objective of this study was to determine the inde-
endent contribution of the anesthesia type used during
EA to the postoperative occurrence of stroke, MI, and
eath, by examining the largest cohort of carotid endarter-
ctomies studied to date in the rigorously maintained,
rospectively collected database of the American College of
81
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gram (ACS NSQIP).
METHODS
This study was approved by the Institutional Review
Board at Saint Joseph Mercy Health System. Retrospective
analysis of CEA cases from 2005 through 2009 in the ACS
NSQIP database was performed. This quality improvement
program originated in the Veterans Affairs system almost 2
decades ago, and the ACS NSQIP database is maintained
by the American College of Surgeons. Over 100 precisely
defined variables are collected on surgical patients, includ-
ing demographic characteristics, comorbidities, laboratory
values, intraoperative events, and 30-day postoperative
outcomes. During the study period, more than 200 partic-
ipating hospitals nationwide systematically collected these
data prospectively. Data abstractors (“clinical nurse review-
ers”) at each participating hospital are subjected to initial
certification, continuous training, examination, and audits.
The high quality and validity of the ACS NSQIP database
has been demonstrated in several reports and studies,14-17
and inter-rater reliability audits have demonstrated a dis-
agreement rate on variables in 2008 of 2%.18
Study population. Included in this study were all
cases of elective CEA, as defined by the Common Proce-
dural Terminology (CPT) code 35301. Cases were strati-
fied into the GA group, if the anesthesia type listed in the
ACS NSQIP database was “general anesthesia”; or into the
RA group, if the type of anesthesia listed was “regional,”
“local,” or “monitored anesthesia care.” Additionally, two
subgroups were defined for patients with and without
preoperative neurologic symptoms. Patients were classified
as having symptomatic disease if one or more of the follow-
ing comorbidities were recorded in the ACS NSQIP data-
base: (1) history of stroke with persistent neurologic deficit;
(2) history of stroke without persistent neurologic deficit;
or (3) history of transient ischemic attack (TIA). All other
patients were considered to have asymptomatic carotid
artery disease. Case exclusion criteria were age under 18
years, emergent procedures, patients designated American
Society of Anesthesiologists (ASA) classes 5 and 6, mechan-
ically ventilated patients, comatose patients, the presence of
a central nervous system tumor, the presence of ascites, and
an anesthesia type listed as “epidural,” “spinal,” “none,”
“other,” or “unknown,” which was considered to be a
potentially erroneous entry.
Primary outcomes of interest were postoperative
stroke, MI, and death occurring within 30 days of opera-
tion. Per ACS NSQIP guidelines, a postoperative stroke
was defined by the development of an embolic, thrombotic,
or hemorrhagic vascular accident with motor, sensory, or
cognitive dysfunction persisting for more than 24 hours.
Postoperative MI was documented in the database if the
clinical nurse reviewer found any one of the following
criteria in a patient’s medical record: (1) electrocardiogram
changes indicative of MI (ST segment elevation1 mm in
two or more contiguous leads, new left bundle branch
block, or a new Q-wave in two or more contiguous leads); p2) new elevation of troponin levels greater than three
imes the reference range in the setting of suspected myo-
ardial ischemia; or (3) a physician’s documented diagnosis
f MI.
Secondary outcomes were cardiac arrest requiring car-
iopulmonary resuscitation and length of hospital stay until
ischarge. Additional risk factors for postoperative stroke,
I, and death were determined in a multivariable logistic
egression model, after stratifying on propensity score
uintile and controlling for significant covariates.
Statistical analysis. Initial comparisons of baseline
emographic and clinical characteristics for the GA and RA
roups were made using Pearson 2 tests for categorical
ariables and independent sample t-tests for continuous
ariables. Initial unadjusted estimates of the incidence of
ostoperative stroke, MI, and death in the GA and RA
roup were calculated. A multivariable logistic regression
nalysis was performed to predict each postoperative out-
ome after stratifying on propensity score quintile and
ncluding any other covariates that had been found to be
ignificant predictors of each outcome in an initial simple
ogistic regression model.
Because this was not a randomized controlled trial, it
as expected that patients in the GA group and the RA
roup would differ in some clinical characteristics. To aid in
aking an unbiased comparison between patient groups,
nd to adjust for the potential differences between patients
n these two anesthesia groups, a propensity score analysis
as used.19 To implement the propensity score method,
he probability of receiving GA was estimated for each
atient using a multivariate logistic regression model, based
n a list of covariates likely to be related to the choice of
nesthesia type. These covariates included 45 baseline char-
cteristics: demographic factors, comorbidities, stroke his-
ory, measures of general health, and laboratory values.
Missing data were found for some laboratory values. To
llow for the inclusion of these cases, each test result was
lassified as normal, abnormal, or missing, in which case a
ummy variable was included in the propensity score
odel. The propensity score model also included interac-
ion terms, where appropriate, to improve the model fit. To
nsure that the propensity score method had produced
omparable groups, the balance for covariates between the
wo anesthesia groups was assessed after propensity score
djustment by using a logistic regression stratified on pro-
ensity score quintile for categorical predictors and an
nalysis of variance model controlling for propensity score
uintile for continuous predictors.
The relationship of anesthesia type to stroke, MI, and
eath was then estimated in the entire study population and
n the two subgroups of asymptomatic and symptomatic
atients, using a logistic regression analysis for each out-
ome, stratified on propensity score quintile, as reported by
ubin.19 The Breslow-Day test20 for homogeneity of odds
atios (ORs) was used to ascertain whether the stratified
Rs for anesthesia type were consistent across propensity
core quintiles. A nonsignificant Breslow-Day test would
rovide evidence that the relationship between anesthesia
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Volume 56, Number 1 Leichtle et al 83type and outcome of interest did not differ significantly
between patients with varying propensities to undergo
CEA under GA or RA. Statistical significance for all analyses
was indicated by P  .05. Analyses were performed using
SAS software for Windows, release 9.2 (SAS Inc, Cary,
NC).
RESULTS
The ACS NSQIP database listed 26,950 carotid end-
arterectomies (CPT code 35301) between 2005 and
Table I. Case details and selected variables in the GA grou
propensity scorea
Risk factors
Anest
GA No. (%) 22,054 (84.
Demographics
Age (mean, SD) 70.9 (9.6)
Female 9150 (41.5)
African American 570 (2.6)
Body mass index 25 kg/m2 8457 (38.4)
General factors
Tobacco use 6288 (28.5)
ASA class
1: Healthy 41 (0.2)
2: Mild systemic disease 2051 (9.3)
3: Severe systemic disease 17,078 (77.4)
4: Severe systemic disease (life-
threatening) 2886 (13.1)
Functional status
Partially dependent 1092 (5.0)
Totally dependent 98 (0.4)
Neurovascular comorbidities
History of TIA 6123 (27.8)
History of stroke (persistent deficit) 3379 (15.3)
History of stroke (without
persistent deficit) 2033 (9.22)
Hemiplegia 1304 (5.9)
Impaired sensorium 143 (0.7)
History of peripheral vascular
disease 2114 (9.6)
History of peripheral vascular
disease (with pain at rest) 202 (0.9)
Cardiac comorbidities
Antihypertensive medication 18,777 (85.1)
History of congestive heart
failure (within 30 days) 216 (1.0)
History of angina (within 30 days) 601 (2.7)
History of MI (within 6 months) 349 (1.6)
History of percutaneous coronary
intervention 4084 (18.5)
History of cardiac surgery 5103 (23.1)
Abnormal laboratory values
White blood cells 885 (4.0)
Hematocrit 7471 (33.9)
Platelet count 1544 (7.0)
Creatinine 5761 (26.1)
International normalized ratio 521 (2.4)
ASA, American Society of Anesthesiologists; GA, general anesthesia; MI
comparison with each covariate); SD, standard deviation; TIA, transient isc
aThe complete table, including all variables used in the propensity score mo
bDenotes P  .05.2009, with 26,070 cases meeting inclusion criteria. GA (as used in 22,054 (84.6%) cases, while RA was used in
016 (15.4%) cases. Of the entire group, 56.4% (n 
4,716) were asymptomatic, while 43.6% (n  11,354)
ere symptomatic. A comparison of selected demo-
raphic characteristics, comorbidities, and other clinical
ariables for the GA group and the RA group before and
fter adjusting for propensity score quintile is shown in
able I (the complete Table I, including all variables
sed for the propensity score model, is available online
nly). Twenty of the 45 covariates differed significantly
d the RA group before and after stratification on
method P value for comparison
RA No. (%) 4016 (15.4)
Before propensity
score adjustment
After propens
score adjustme
72.0 (9.4) .01b .80
1587 (39.5) .02b .87
70 (1.7) .01b .82
1600 (39.8) .03b .84
1007 (25.1) .01b .89
3 (0.1) .25 .57
423 (10.5) .01b .51
3166 (78.8) .01b .84
424 (10.6) Ref Ref
195 (4.9) .03b .89
8 (0.2) .77 .38
1100 (27.4) .63 .90
512 (12.8) .01b .82
358 (8.9) .54 .95
163 (4.1) .01b .70
24 (0.6) .71 .99
354 (8.8) .12 .94
47 (1.2) .13 .87
3460 (86.2) .10 .93
35 (0.9) .52 .83
87 (2.2) .04b .86
48 (1.2) .07 .82
750 (18.7) .81 .98
918 (22.9) .70 .94
154 (3.8) .29 .97
1289 (32.1) .47 .83
280 (7.0) .93 .95
1045 (26.0) .81 .96
110 (2.7) .05b .52
cardial infarction; RA, regional anesthesia; Ref, reference category (for
attack.
n be accessed online.p an
hetic
6)
, myo
hemicP  .05) between the two groups prior to stratification
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July 201284 Leichtle et alby propensity score. After stratification, no significant
difference was found between the GA group and the RA
group for any of these variables, indicating that the
propensity score method had eliminated the initial dif-
ferences between the two groups and provided marginal
balance on these measured covariates.
The Breslow-Day test for homogeneity of ORs was
nonsignificant for each outcome (stroke, P .46; MI, P
.49; death, P  .22), indicating that the ORs calculated
were similar across the five propensity score strata, regard-
less of the probability of a patient to undergo CEA under
GA or RA.
Postoperative stroke, MI, and death occurred in 360
(1.63%), 133 (0.6%), and 154 (0.70%) patients in the GA
group, respectively. Postoperative stroke, MI, and death
occurred in 58 (1.44%), 11 (0.27%), and 27 (0.67%) pa-
tients in the RA group, respectively. Unadjusted and
propensity-score adjusted OR and 95% confidence intervals
(CI) for stroke, MI, and death in the entire study popula-
tion demonstrated a significantly increased risk for MI with
GA and are shown in Table II. Additional predictors for
postoperative MI determined by multivariable logistic re-
gression were age and a history of angina within 30 days
prior to the operation (OR, 1.04; 95% CI, 1.02 to 1.06;
P  .001, and OR, 2.83; 95% CI, 1.52 to 5.25; P  .001,
respectively).
Postoperative stroke, MI, and death in 12,343 asymp-
tomatic patients who underwent CEA under GA occurred
in 136 (1.10%), 65 (0.53%), and 65 (0.53%) cases, respec-
tively. In 2373 asymptomatic patients who underwent
CEA under RA, postoperative stroke, MI, and death oc-
curred in 24 (1.01%), nine (0.38%), and 13 (0.55%) pa-
tients, respectively. Unadjusted and propensity-score ad-
Table II. Unadjusted and adjusted ORs for stroke, MI, an
population
Outcome
Before propensity score adjustment
OR 95% CI
Stroke 1.13 0.86-1.49
MI 2.21 1.19-4.09
Death 1.04 0.69-1.57
CEA, Carotid endarterectomy; CI, confidence interval; GA, general anesthe
aDenotes statistical significance with P  .05.
Table III. Unadjusted and adjusted ORs for stroke, MI, a
of neurologic symptoms
Outcome
Before propensity score adjustment
OR 95% CI
Stroke 1.09 0.71-1.69
MI 1.39 0.69-2.79
Death 0.96 0.53-1.75
CEA, Carotid endarterectomy; CI, confidence interval; MI, myocardial infajusted OR and 95% CI for stroke, MI, and death in isymptomatic patients did not demonstrate any significant
ssociations and are shown in Table III. Multivariable
ogistic regression analysis determined age and a history of
ngina within 30 days prior to the operation to be signifi-
ant predictors for postoperative MI (OR, 1.06; 95% CI,
.02 to 1.09; P  .001, and OR, 3.79; 95% CI, 1.61 to
.91; P  .002, respectively).
Postoperative stroke, MI, and death in 9711 symptom-
tic patients who underwent CEA under GA occurred in
24 (2.31%), 68 (0.70%), and 89 (0.92%) cases, respec-
ively. In 1643 symptomatic patients who underwent CEA
nder RA, postoperative stroke, MI, and death occurred in
4 (2.07%), two (0.12%), and 13 (0.79%) patients, respec-
ively. Unadjusted and propensity-score adjusted OR and
5% CI for stroke, MI, and death in symptomatic patients
emonstrated a significantly increased risk for MI with GA
nd are shown in Table IV. A significant risk factor for
ostoperative MI determined by multivariable logistic re-
ression was an abnormal hematocrit level (OR, 1.70; 95%
I, 1.01 to 2.87; P  .05).
Additional significant risk factors for stroke and death
n symptomatic and asymptomatic patients and in the entire
tudy population are shown in Table V (online only).
Postoperative cardiac arrest occurred in 73 (0.28%)
ases. It occurred in 0.30% of patients in the GA group (n
7) and in 0.15% of patients in the RA group (n 6). This
rend did not quite reach statistical significance (P  .08).
The difference in the length of hospital stay (LOS;
ean  SD) was highly significant between the GA group
ith 2.08 3.60 days and the RA group with 1.68 2.81
ays (P .0001). LOS increased to 7.29 (8.08) days and
.45 (10.24) days in the GA and RA groups, respectively,
ath after CEA under GA versus RA for the entire study
After propensity score adjustment
e OR 95% CI P value
1.06 0.79-1.39 .71
2.18 1.17-4.04 .01a
0.99 0.65-1.49 .95
I, myocardial infarction; OR, odds ratio; RA, regional anesthesia.
eath after CEA in patients without a preoperative history
After propensity score adjustment
e OR 95% CI P value
1.07 0.69-1.67 .75
1.44 0.71-2.90 .31
0.93 0.51-1.70 .82
; OR, odds ratio.d de
P valu
.38
.01a
.86nd d
P valu
.70
.36
.89n patients with postoperative MI.
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In this analysis of the large, multicenter ACS NSQIP
database, GA was found to be an independent risk factor for
MI after CEA. The odds for this complication were partic-
ularly high in the subgroup of patients with preoperative
neurologic symptoms. Anesthesia type did not influence
the incidence of postoperative stroke or death. The overall
rate of stroke, MI, and death after CEA in both symptom-
atic and asymptomatic patients was extremely low. These
findings are similar to those in a previous ACS NSQIP
analysis of only asymptomatic patients.8
A retrospective review suggesting that RA with peripro-
cedural neurologic monitoring results in fewer cardiopul-
monary complications and may be safer than GA was pub-
lished as early as 1982.21 After the dramatic increase
in the volume of CEAs following NASCET1 and ECST,2
several subsequent studies demonstrated varying results
regarding the type of anesthesia used and cardiovascular
complications. Watts et al22 performed a retrospective re-
view of 548 cases of CEA and reported a significantly
higher rate of MI with GA (8.4%) than with RA (2.3%). The
authors suggested that higher rates of hemodynamic vari-
ability in patients undergoing CEA under GA could be
responsible for this finding. Allen et al11 reviewed 584 cases
of CEA performed for predominantly symptomatic patients
and found fewer postoperative cardiac complications with
the use of RA. They did not report any significant difference
in the occurrence of postoperative stroke and death. In
addition, they found RA to be more resource-efficient,
leading to fewer intraoperative shunt insertions and shorter
postoperative LOS.11 In our study, patients in the GA
group also had a significantly longer LOS than patients in
the RA group. Considering the small absolute difference
(2.08 vs 1.68 days), this statistically significant difference
may not represent a clinically significant difference.
Similar findings with regard to anesthesia type were
reported by McCarthy et al,23 who prospectively analyzed
240 patients undergoing CEA under GA and RA. No
significant difference between GA and RA was found in
regard to perioperative stroke and mortality. Postoperative
MI was not among the outcomes studied. RA was shown to
result in fewer episodes of intraoperative hypotension,
which may be beneficial for patients at risk for myocardial
ischemia. In addition to a significantly lower rate of intra-
Table IV. Unadjusted and adjusted ORs for stroke, MI, a
neurologic symptoms
Outcome
Before propensity score adjustment
OR 95% CI
Stroke 1.12 0.78-1.61
MI 5.78 1.42-23.61
Death 1.08 0.61-1.90
CEA, Carotid endarterectomy; CI, confidence interval; MI, myocardial infa
aDenotes statistical significance with P  .05.operative shunting and improved hemodynamic stability, ahis study also demonstrated a decreased LOS and better
ost-effectiveness, results similar to other studies.24,25
The benefits of RA for CEA suggested in multiple
etrospective analyses and cohort studies were not con-
rmed in the largest prospective clinical trial to date
GALA). This multinational, multicenter trial randomized
526 patients with symptomatic and asymptomatic carotid
isease to CEA under either GA or RA and examined a
rimary composite outcome of stroke, MI, and death
ithin 30 days of CEA. The study population was similar to
atients included in the ACS NSQIP with regard to several
emographic characteristics and comorbidities, but GALA
ncluded substantially more tobacco users (80% vs 27%) and
ewer asymptomatic patients (39% vs 56%). More patients
n GALA were classified as ASA classes 1 and 2 (65% vs
0%), whereas almost 90% of patients in the ACS NSQIP
atabase belonged to ASA classes 3 and 4. A statistically
ignificant difference between GA and RA with regard to
he occurrence of the composite outcome, or the occur-
ence of either stroke, MI, or death individually, was not
emonstrated in GALA. This was true for symptomatic and
symptomatic patients.13
Even though results from the GALA trial suggest that
A and RA are equivalent with regard to postoperative
omplications, there were several interesting observations
nd trends that differed between anesthesia type. In pa-
ients with contralateral carotid artery occlusion, the com-
osite outcome occurred twice as often in patients under
A than RA, with an OR of 0.47 (0.20 to 1.15), a trend
hat failed to reach statistical significance (P  .098). With
egard to hemodynamic stability, there was a significant
ifference between anesthesia types, with patients in the
A group requiring vasopressor support more often than
atients in the RA group (P  .001). Hemodynamic sta-
ility might have contributed to the trend seen in our
esults that demonstrated fewer intra- and postoperative
ardiac arrests in the RA group than in the GA group,
hich did not quite reach statistical significance. Finally, a
ost-effectiveness analysis of the GALA trial25 demon-
trated a slight economic advantage of RA over GA, mostly
result of less intraoperative device use (shunts) and shorter
ime in the intensive care unit.
In the current study, anesthesia type did not influence
he incidence of intra- and postoperative cerebrovascular
eath after CEA in patients with a preoperative history of
After propensity score adjustment
e OR 95% CI P value
1.03 0.71-1.48 .89
5.41 1.32-22.16 .019a
1.04 0.59-1.85 .89
; OR, odds ratio.nd d
P valu
.55
.01a
.80ccidents, which is in accordance with most existing stud-
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July 201286 Leichtle et alies.26 Nevertheless, several authors consider RA to be safer
from a neurologic perspective, because it allows for contin-
uous monitoring of cognitive function and early detection
of cerebral hypoperfusion. In addition, patients undergo-
ing CEA under RA generally require fewer shunt insertions,
thus avoiding associated thromboembolic complications.
These patients may also have improved cerebral circula-
tion27 and autoregulation.28 Short-term stroke rates after
CEA have been reported to be as low as 1%8 or more than
5%,7,11 with the extremes reflecting low-risk, asymptomatic
and high-risk, symptomatic patients, respectively. Major
risk factors for postoperative stroke include symptomatic
carotid artery stenosis and various systemic factors, includ-
ing advanced age, cardiac disease, diabetes, and limited
functional status.6,7 These findings suggest that clinical
status and comorbidities, both of which were adjusted for
in the propensity model, might be more important deter-
minants of perioperative stroke rate associated with CEA
than anesthesia type. Given the severe implications of cere-
brovascular accidents on patients’ quality of life, minimiz-
ing the risk of perioperative stroke is arguably of highest
priority.
The higher incidence of perioperative cardiac compli-
cations under GA may be explained by the complex patho-
physiologic processes of myocardial ischemia, which are the
consequence of a mismatch between increased oxygen de-
mand (in the operative setting frequently caused by cate-
cholamine release, tachycardia, or the use of vasoactive
medication) and decreased oxygen supply. The latter factor
can be influenced by the hemodynamic effects of GA;
postinduction hypotension is a common effect of general
anesthetics,29 and lower mean arterial pressures with GA
than with RA were demonstrated in both clinical trials27
and database analyses.23,30 GA can negatively affect the
balance between sympathetic and parasympathetic tone,
and GA has been found to cause a greater degree of
hemodynamic instability, leading to more variation in sys-
tolic blood pressure and heart rate during the intra- and
postoperative phase, subsequently increasing the demand
for vasoactive medication.10,30,31 GA might also have a
more profound influence on the coagulation system, thus
increasing the risk for thromboembolic events.32,33
While anesthesia type only influenced the occurrence of
postoperative MI, this study identified several patient-
related risk factors that were significantly associated with an
increased risk for postoperative stroke, MI, or death. In
general, older patients with severe comorbidities, such as
chronic obstructive pulmonary disease or peripheral vascu-
lar disease, were at higher risk for postoperative death,
while more specific cardiac (eg, angina within 30 days prior
to the operation) and neurologic (eg, history of stroke or
TIA) comorbidities increased the risk for postoperative MI
and stroke, respectively. Similar associations were also dem-
onstrated in two recent ACS NSQIP analyses focusing on
the identification of preoperative risk factors for postop-
erative complications.8,34 The risk factors identified in
these studies were not identical to those determined in
this analysis and also differed among each other. This eay be explained by the smaller dataset used in these
tudies, different primary outcomes, and/or by varia-
ions in the statistical models.
The strength of this study is that it is derived from a
arge, rigorously maintained, and prospectively collected
atabase from more than 200 hospitals in the U.S. The
ighly trained and certified ACS NSQIP clinical nurse
eviewers are experienced in abstracting these clinical vari-
bles and provide high-quality data.15,17,18 With over
6,000 cases, this is the largest cohort of CEA cases studied
o date. The large study population in our database is
articularly important when evaluating outcomes that are
evere but infrequent, such as stroke and death after CEA,
he evaluation of which is difficult to achieve in a random-
zed controlled trial. Participating institutions nationwide
ange from small community hospitals to large academic
enters, and the study population therefore reflects a spec-
rum of demographics and comorbidities encountered in
veryday clinical practice, compared with the often highly
elective patient population studied in randomized con-
rolled trials. Additionally, database analyses avoid the eth-
cal and financial problems frequently encountered in clin-
cal trials.
Using logistic regression and stratification on propen-
ity score allowed us to reduce the bias inherent to data-
ases and to determine the independent contribution of
nesthesia type to postoperative complications. The pro-
ensity score method was successful in removing differ-
nces between the groups on all chosen variables. The
ffectiveness of propensity score models to adjust for the
ifferences between several study groups has been demon-
trated previously.35-38
However, the analysis of a surgical database that lacks
pecific vascular data has several limitations. No informa-
ion was available regarding specific preoperative assess-
ent for vascular disease and cardiac testing. The precise
egree of carotid artery stenosis and the presence of con-
ralateral carotid artery stenosis were not known. The ACS
SQIP database did not record data on the utilization of
ntiplatelet agents or perioperative -blockers. Specifics
bout the anesthesia types used (beyond GA or RA) and
perative details, such as the use of intraoperative shunting,
ere not available. Additionally, patients in the ACS
SQIP database were not subjected to increased postop-
rative surveillance or additional testing, and therefore
ore specific information about postoperative stroke and
I such as severity of symptoms was not available. Finally,
s propensity score stratification for patient matching does
ot represent true randomization, it can only adjust for
nown and measured confounders, and missing informa-
ion in the database, particularly among laboratory values,
equired the introduction of dummy variables in the statis-
ical model.
ONCLUSIONS
GA is associated with an increased risk for MI after
EA, particularly in the subgroup of patients with preop-
rative neurologic symptoms. In eligible patients and at
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2
2
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Volume 56, Number 1 Leichtle et al 87institutions experienced in this technique, regional anes-
thesia should be considered the anesthetic type of choice.
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propensity score
Risk factors
Anesthetic method P value for comparison
GA No. (%)
22,054 (84.6)
RA No. (%)
4016 (15.4)
Before propensity score
adjustment
After propensity score
adjustment
Demographics
Age (mean, SD) 70.9 (9.6) 72.0 (9.4) .01a .80
Female 9150 (41.5) 1587 (39.5) .02a .87
Race
White 12,210 (55.4) 2148 (53.5) Ref Ref
African American 570 (2.6) 70 (1.7) .01a .82
Missing 9274 (42.1) 1798 (44.8) .01a .96
Body mass index category
Underweight 401 (1.8) 69 (1.7) .95 .96
Normal 5839 (26.5) 1093 (27.2) .09 .96
Overweight 8457 (38.4) 1600 (39.8) .03a .84
Obese 7021 (31.8) 1217 (30.3) Ref Ref
Missing 336 (1.5) 37 (0.9) .01a .46
General factors
Tobacco use 6288 (28.5) 1007 (25.1) .01a .89
Alcohol abuse 978 (4.4) 161 (4.1) .23 .97
ASA class
1: Healthy 41 (0.2) 3 (0.1) .25 .57
2: Mild systemic disease 2051 (9.3) 423 (10.5) .01a .51
3: Severe systemic disease 17,078 (77.4) 3166 (78.8) .01a .84
4: Severe systemic disease (life-
threatening) 2886 (13.1) 424 (10.6) Ref Ref
Functional status
Independent 20,864 (94.6) 3813 (95.0) Ref Ref
Partially dependent 1092 (5.0) 195 (4.9) .03a .89
Totally dependent 98 (0.4) 8 (0.2) .77 .38
Prior operation (within 30 days)
No 20,022 (90.8) 3716 (1.4) Ref Ref
Yes 252 (1.1) 57 (1.4) .18 .94
Missing 1780 (0.1) 243 (6.1) .01a .89
Sepsis/SIRS 176 (0.8) 26 (0.7) .32 .90
Neurovascular comorbidities
History of TIA 6123 (27.8) 1100 (27.4) .63 .90
History of stroke (persistent deficit) 3379 (15.3) 512 (12.8) .01a .82
History of stroke (without persistent
deficit) 2033 (9.22) 358 (8.9) .54 .95
Hemiplegia 1304 (5.9) 163 (4.1) .01a .70
Impaired sensorium 143 (0.7) 24 (0.6) .71 .99
History of peripheral vascular disease 2114 (9.6) 354 (8.8) .12 .94
History of peripheral vascular disease
(with pain at rest) 202 (0.9) 47 (1.2) .13 .87
Cardiac comorbidities
Antihypertensive medication 18,777 (85.1) 3460 (86.2) .10 .93
History of congestive heart failure
(within 30 days) 216 (1.0) 35 (0.9) .52 .83
History of angina (within 30 days) 601 (2.7) 87 (2.2) .04a .86
History of MI (within 6 months) 349 (1.6) 48 (1.2) .07 .82
History of percutaneous coronary
intervention
4084 (18.5) 750 (18.7) .81 .98
History of cardiac surgery 5103 (23.1) 918 (22.9) .70 .94
Pulmonary comorbidities
Current pneumonia 33 (0.2) 4 (0.1) .44 .93
Dyspnea
None 17,773 (80.6) 3285 (81.8) Ref Ref
At rest 271 (1.2) 47 (1.2) .69 .99
With moderate exertion 4010 (18.2) 684 (17.0) .08 .99
ASA, American Society of Anesthesiologists; GA, general anesthesia; MI, myocardial infarction; RA, regional anesthesia; Ref, reference category (for
comparison with each covariate); SD, standard deviation; SIRS, systemic inflammatory response syndrome; TIA, transient ischemic attack.
aP  .05.
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Risk factors
Anesthetic method P value for comparison
GA No. (%)
22,054 (84.6)
RA No. (%)
4016 (15.4)
Before propensity score
adjustment
After propensity score
adjustment
History of severe chronic obstructive
pulmonary disease 2271 (10.3) 399 (9.9) .49 .97
Chemotherapy (within 30 days) 49 (0.2) 14 (0.4) .14 .70
Disseminated cancer 52 (0.2) 8 (0.2) .66 .98
Weight loss 10% (within 6 months) 130 (0.6) 25 (0.6) .80 .83
Renal comorbidities
Hemodialysis 221 (1.0) 33 (0.8) .29 .99
Endocrine/other comorbidities
Diabetes 6091 (27.6) 1083 (27.0) .40 .95
Steroids 460 (2.1) 86 (2.1) .82 .93
Bleeding disorder 4481 (20.3) 815 (20.3) .97 .96
White blood cells
No 18,570 (84.2) 3394 (84.5) Ref Ref
Yes 885 (4.0) 154 (3.8) .29 .97
Missing 2599 (11.8) 469 (11.7) .78 .98
Hematocrit
No 11,454 (51.9) 2215 (52.9) Ref Ref
Yes 7471 (33.9) 1289 (32.1) .47 .83
Missing 3129 (14.2) 602 (15.0) .06 .96
Platelet count
No 18,681 (84.7) 3407 (84.8) Ref Ref
Yes 1544 (7.0) 280 (7.0) .93 .95
Missing 1829 (8.29) 329 (8.2) .83 .97
Blood urea nitrogen
No 19,796 (88.8) 3473 (86.5) Ref Ref
Yes 803 (3.6) 161 (4.0) .13 .79
Missing 1455 (6.6) 382 (9.5) .01a .15
Creatinine
No 15,302 (69.4) 2750 (68.5) Ref Ref
Yes 5761 (26.1) 1045 (26.0) .81 .96
Missing 991 (4.5) 221 (5.5) .01a .88
Prothrombin time
No 12,613 (57.2) 2094 (52.1) Ref Ref
Yes 2076 (9.4) 344 (8.6) .01a .67
Missing 7365 (33.4) 1578 (39.3) .01a .55
International normalized ratio
No 15,449 (70.0) 2639 (65.7) Ref Ref
Yes 521 (2.4) 110 (2.7) .05a .52
Missing 6084 (27.6) 1267 (31.6) .01a .79
Partial thromboplastin time
No 12,613 (57.2) 2094 (52.1) Ref Ref
Yes 2076 (9.4) 344 (8.6) .98 .98
Missing 7365 (33.4) 1578 (39.3) .01a .60
Aspartate amino transferase
No 10,092 (45.8) 1693 (42.2) Ref Ref
Yes 727 (3.3) 110 (2.7) .33 .99
Missing 11,235 (50.9) 2213 (55.1) .01a .71
Albumin
No 9787 (44.4) 1600 (39.8) Ref Ref
Yes 697 (3.2) 123 (3.1) .45 .99
Missing 11,570 (52.5) 2293 (57.1) .01a .88
Alkaline phosphatase
No 9802 (44.5) 1547 (38.5) Ref Ref
Yes 650 (3.0) 103 (2.6) .97 .97
Missing 11,602 (52.6) 2366 (58.9) .01a .53
Bilirubin
No 9580 (43.4) 1515 (37.7) Ref Ref
Yes 793 (3.6) 126 (3.1) .96 .97
aMissing 11,681 (53.0) 2375 (59.1) .01 .56
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Volume 56, Number 1 Leichtle et al 88.e3Table V (online only). Significant risk factors for stroke and death after carotid endarterectomy in the entire study
population and in patients with and without a preoperative history of neurologic symptoms
Outcome Preoperative risk factor P value
Stroke (all patients) Angina (within 30 days prior to operation) .03
Hemiplegia .01
Stroke without persistent neurologic deficit .01
Stroke with persistent neurologic deficit .0001
Transient ischemic attack .001
Stroke (symptomatic patients) Hemiplegia .01
Stroke without persistent neurologic deficit .01
Stroke with persistent neurologic deficit .001
Transient ischemic attack .02
Stroke (asymptomatic patients) Angina (within 30 days prior to operation) .05
Functional status (partially dependent) .01
Myocardial infarction (within 6 months prior to operation) .05
Death (all patients) Age .001
Chronic obstructive pulmonary disease .01
Disseminated cancer .01
Dyspnea (with moderate exertion) .01
Impaired sensoriuma .01
Myocardial infarction (within 6 months prior to operation) .05
Peripheral vascular disease .001
Death (symptomatic patients) Age .01
Disseminated cancer .02
Peripheral vascular disease .001
Prior operation within 30 days .01
Death (asymptomatic patients) Age .001
Chronic obstructive pulmonary disease .001
Impaired sensoriuma .01
Myocardial infarction (within 6 months prior to operation) .01aDefined as mental status change (confusion and/or delirium) within 48 hours prior to the operation.
